Zheng Yong Selected Research

LCX001

1/2019

The Impact and Mechanism of a Novel Allosteric AMPA Receptor Modulator LCX001 on Protection Against Respiratory Depression in Rodents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zheng Yong Research Topics

Disease

6	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 09/2014
4	Opioid-Related Disorders (Opiate Addiction) 10/2016 - 04/2012
2	Chronic Pain 01/2022 - 11/2018
2	Cognitive Dysfunction 01/2021 - 01/2020
2	Pain (Aches) 08/2017 - 10/2016
1	Neoplasms (Cancer) 08/2020
1	Carcinogenesis 08/2020
1	Glioma (Gliomas) 08/2020
1	Memory Disorders (Memory Loss) 01/2020
1	Spasm (Spasms) 10/2016
1	Renal Colic 10/2016
1	Alcoholism (Alcohol Abuse) 07/2014
1	Body Weight (Weight, Body) 07/2014
1	Osteoporosis 01/2014
1	Breast Neoplasms (Breast Cancer) 01/2011
1	Hypoxia (Hypoxemia) 09/2010
1	Hypertension (High Blood Pressure) 09/2010
1	Pulmonary Hypertension 09/2010

Drug/Important Bio-Agent (IBA)

5	Opioid Analgesics (Opioids)IBA 01/2022 - 10/2016
4	Pharmaceutical PreparationsIBA 01/2021 - 09/2010
3	Fentanyl (Sublimaze)FDA LinkGeneric 01/2022 - 11/2018
3	thienorphineIBA 10/2016 - 04/2012
2	Hypnotics and Sedatives (Sedatives)IBA 01/2022 - 01/2019
2	Analgesics (Analgesic Drugs)IBA 01/2022 - 01/2019
2	Opioid Receptors (Opioid Receptor)IBA 01/2022 - 11/2013
2	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2021 - 01/2020
2	7- (1- hydroxy- 1- methyl- 3- (thien- 3- yl)propyl)- 6,14- ethanotetrahydrooripavineIBA 01/2019 - 08/2017
2	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2019 - 04/2016
2	Naloxone (Narcan)FDA LinkGeneric 08/2017 - 09/2014
1	BenzodiazepinesIBA 01/2022
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	tandospironeIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2020
1	Adenosine Triphosphate (ATP)IBA 08/2020
1	3- (4'- hydroxy- 3'- adamantylbiphenyl- 4- yl)acrylic acidIBA 08/2020
1	RetinoidsIBA 08/2020
1	Illicit Drugs (Recreational Drugs)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	ursodoxicoltaurineIBA 01/2020
1	Pentobarbital (Nembutal)FDA Link 01/2019
1	LCX001IBA 01/2019
1	Propofol (Diprivan)FDA LinkGeneric 01/2019
1	AMPA Receptors (AMPA Receptor)IBA 01/2019
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 11/2018
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 11/2018
1	Phosphodiesterase 4 InhibitorsIBA 11/2018
1	Adenosine Monophosphate (AMP)IBA 11/2018
1	Morphine (MS Contin)FDA LinkGeneric 10/2016
1	Glutamate Receptors (Glutamate Receptor)IBA 04/2016
1	Opiate AlkaloidsIBA 04/2016
1	AcidsIBA 04/2016
1	nalmefene (Revex)FDA Link 09/2014
1	Naltrexone (ReVia)FDA LinkGeneric 09/2014
1	carfentanil (carfentanyl)IBA 09/2014
1	Glycine Receptors (Glycine Receptor)IBA 07/2014
1	Ethanol (Ethyl Alcohol)IBA 07/2014
1	CalciumIBA 01/2014
1	Methadone (Dolophine)FDA LinkGeneric 03/2013
1	Buprenorphine (Subutex)FDA LinkGeneric 03/2013
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2011
1	Endothelins (Endothelin)IBA 09/2010
1	Endothelin-1 (Endothelin 1)IBA 09/2010
1	Endothelin A ReceptorIBA 09/2010
1	di- n- butylaminocarbamyl- leucyl- tryptophyl- 4- chlorophenylalanineIBA 09/2010

Therapy/Procedure

1	Therapeutics 08/2020
1	Analgesia 08/2017
1	Intravenous Administration 09/2014
1	Drug Therapy (Chemotherapy) 07/2014
1	Ovariectomy (Oophorectomy) 01/2014